Introduced
Passed House
Passed Senate
Became law
Adjourned sine die. The bill was pending when the session ended, so it did not pass.
Last action · January 29, 2026
To Banking & Insurance (H)

Introduced January 21, 2026

House
Adjourned Sine Die
2026 Regular Session

AN ACT relating to prescription drugs.

Amend KRS 304.17A-164 to define terms; prohibit insurers and administrators from requiring insureds to pay cost sharing for a prescription drug that is greater than the cash price; require insurers and administrators to count the amount paid for a covered prescription drug towards the insured's cost-sharing if certain requirements are met; establish requirements for insurers, administrators, and pharmacies for submission of cash price paid by an insured; exempt a state employee health plan from counting…

AI-generated. Always verify with primary sources
Plain-language summary
Beta

This bill sets new rules for how health insurers and pharmacies handle the out-of-pocket costs Kentuckians pay for prescription drugs. It would prevent insurers from charging a patient more than the cash price for a drug, and it would require that money a patient pays toward a prescription count against their deductible or other cost-sharing limits. These rules would apply to most health plans issued or renewed on or after January 1, 2027, including plans…

Open official bill text (PDF)·Report a problem with the summary

Legislative History

Jan 21, 2026 · House
Introduced In House
Jan 21, 2026 · House
To Committee On Committees (H)
Jan 29, 2026 · House
To Banking & Insurance (H)

Primary Sponsor

View profile
Portrait of Patrick Flannery

Patrick Flannery

Representative · House District 096

Primary sponsor
Patrick.Flannery@kylegislature.gov

Bill Text Versions

Introduced (original)

Most current
Read

Something wrong on this page? Tell us